Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

Natick man William “Joey” Howard, 74, died from lung cancer and esophageal cancer in May of 2023 — a “premature and ...

Doctors at Delray Medical Center are combining AI and robotics to help detect lung cancer earlier and potentially save more ...

Immutep (ASX:IMM) has dosed the first patient in its pivotal Phase III trial evaluating eftilagimod alfa (efti) for the ...

AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.

A man was told he had terminal cancer after Southland Hospital failed to spot cancer developing in his lung over five years ...

CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED, savolitinib and surufatinib, will be presented at the ...

THE SCREENING CAN ALSO DETECT LUNG CANCER IN PATIENTS WHO DON’T EVEN ... if the cancerous spot is less than an inch and hasn't spread, patients can achieve the same cure rate with a smaller ...

Title: TACTI-004: a double-blinded, randomized phase 3 trial in patients with advanced/metastatic non-small cell cancer ...